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Background:Multimodal measurements combining broadband near-infrared spectroscopy (NIRS) and phospho-
rus magnetic resonance spectroscopy (31P MRS) assessed associations between changes in the oxidation state of
cerebral mitochondrial cytochrome-c-oxidase (Δ[oxCCO]) and 31P metabolite peak-area ratios during and after
transient cerebral hypoxia–ischemia (HI) in the newborn piglet.
Methods: Twenty-four piglets (aged b 24 h) underwent transient HI (inspired oxygen fraction 9% and bilateral
carotid artery occlusion for ~20 min). Whole-brain 31P MRS and NIRS data were acquired every minute.
Inorganic phosphate (Pi)/epp, phosphocreatine (PCr)/epp, and total nucleotide triphosphate (NTP)/epp were
measured by 31P MRS and were plotted against Δ[oxCCO] during HI and recovery (epp = exchangeable
phosphate pool = Pi + PCr + 2γ-NTP + β-NTP).
Results: During HI Δ[oxCCO], PCr/epp and NTP/epp declined and Pi/epp increased. Signiﬁcant correlations were
seen between 31P ratios and Δ[oxCCO]; during HI a threshold point was identiﬁedwhere the relationship between
Δ[oxCCO] and bothNTP/epp and Pi/epp changed signiﬁcantly. Outcome at 48 h related to recovery ofΔ[oxCCO] and
31P ratios 1 h post-HI (survived: 1-h NTP/epp 0.22 ± 0.02, Δ[oxCCO] −0.29 ± 0.50 μM; died: 1-h NTP/epp
0.10 ± 0.04, Δ[oxCCO]−2.41 ± 1.48 μM).
Conclusions: Both loweredΔ[oxCCO] and NTP/epp 1 h post-HI indicatedmitochondrial impairment. Animals dying
before 48 h had slower recovery of both Δ[oxCCO] and 31P ratios by 1 h after HI.
© 2013 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
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Neonatal encephalopathy following perinatal hypoxia–ischemia (HI)
is associated with high rates of mortality and morbidity worldwide
(Kurinczuk et al., 2010). Although successful treatment strategies such
as therapeutic hypothermia (Tagin et al., 2012) have been developed
and are in use in the developed world, there is still an urgent need for
novel therapies to improve clinical outcomes. There is also a need to
detect those individuals atmost risk of brain injury andwhomay beneﬁt
from adjunct therapies or redirection of clinical care.
In human infants, phosphorus magnetic resonance spectroscopy
(31P MRS) can be used to study the evolution of cerebral energetic
metabolism following intra-partum HI (Hope et al., 1984). In infants
with eventual adverse outcome, despite adequate oxygenation and
circulation, phosphocreatine (PCr) and nucleotide triphosphate
(NTP—mainly adenosine triphosphate, ATP) decline and inorganic
phosphate (Pi) increases in the ﬁrst days of life (Cady et al., 1997).
These metabolic changes are termed “secondary energy failure”
(SEF) on the basis that they followed primary intra-partum cerebral
energy generation impairment (resulting in transiently reduced PCr
and NTP and increased Pi), which resolved following resuscitation
(Lorek et al., 1994). Since the 1980s there have been few studies
using 31P MRS as outcome biomarkers in babies following asphyxia,
as the 31P MRS facility is not routinely available on clinical scanners,
but the decline in the brain energy measured in this manner in
the days and hours after birth strongly correlates with neuro-
developmental outcome and head growth (Azzopardi et al., 1989).
The main MRS biomarker now used in babies to predict outcome
and as a surrogate outcome measure in clinical neuroprotection
trials (e.g. TOBY Xenon) is the proton magnetic resonance spectros-
copy (1H MRS) thalamic lactate/N acetyl aspartate (NAA) peak area
ratio (Thayyil et al., 2010). Lactate/NAA correlates with the severity
of PCr/Pi decline. 1HMRS is attractive as it is practical and easy, using
the same nucleus as MR imaging, and provides a higher resolution
with smaller voxel sizes compared with 31P MRS. Lactate/NAA is
currently used as a surrogate outcome measure in phase II clinical
trials, see e.g.: www.ClinicalTrials.gov identiﬁer: NCT00934700
Broadband near-infrared spectroscopy (NIRS) provides brain
energetics information complementary to MRS. In adult humans,
NIRS has measured concentration changes in oxygenated haemoglobin
(HbO2), de-oxygenated haemoglobin (HHb), and the oxidation state of
cytochrome-c-oxidase (Δ[oxCCO]) (Tachtsidis et al., 2009, 2011; Tisdall
et al., 2007, 2008a). CCO is the terminal electron acceptor of the mito-
chondrial electron transfer chain and therefore plays a crucial role in
cellular O2 utilization and ATP synthesis (Richter and Ludwig, 2003).
NIRS can be a cotside tool for human neonates and several NIRS instru-
ments monitoring only tissue oxygen saturation (SO2) are approved for
clinical use (Wolf et al., 2007). However, these cerebral oximeters have
attracted speciﬁc criticisms: (i) SO2 alone is not a robust indicator of
sufﬁcient tissue oxygen delivery (Weiss et al., 2005); (ii) the NIRS
measurement has poor reliability compared with SO2 in jugular venousblood (Nagdyman et al., 2005); and (iii) the absolute oxygenation level
is relatively poorly determined (Greisen et al., 2011). However, broad-
bandNIRS enablesΔ[oxCCO]monitoring andmeasuringΔ[oxCCO] during
recovery from HI may provide additional clinical utility.
Our study uses an established piglet model of transient perinatal HI
(Faulkner et al., 2011; O'Brien et al., 2006; Robertson et al., 2012a,
2012b) utilizing 31PMRS toquantify cerebral energymetabolismbefore,
during and after transient HI. Measurement of Δ[oxCCO] in parallel with
31P MRS has been previously reported in the piglet. Cooper and
Springett reported measurement of Δ[oxCCO] contemporaneously
with 31P MRS in a single piglet during HI and up to 40 hof recovery
(Cooper and Springett, 1997). However, 31P MRS temporal resolution
in that work was low, comprising 3 measurements covering baseline
and HI and 4 during the ﬁrst hour of recovery. Springett et al. (2000a)
reported measurements made during brief (105 s) anoxias. Temporal
resolution was better but anoxia was insufﬁcient to reduce NTP
generation.
In this current study, our goal was to ascertain how Δ[oxCCO] corre-
lates with changes in energy metabolism during HI and during early
recovery after reperfusion and re-oxygenation. We achieved this using
broadband NIRS and 31P MRS simultaneously to provide continuous
measurements every 1 min. Our hypothesis was that the extent of
recovery of Δ[oxCCO] and 31P MRS metabolite ratios would correlate
during early recovery post HI.
Methods
Subjects and maintenance
All animal experiments were performed under UK Home Ofﬁce
Guidelines (Animals [Scientiﬁc procedures] act, 1986). Twenty-
four male term-born piglets were anesthetized and surgically prepared
(aged b 24 h) as described previously (Lorek et al., 1994). Brieﬂy, piglets
were sedatedwith intramuscularmidazolam (0.2 mg/kg) andarterial O2
saturation (SpO2)wasmonitored (NoninMedical, USA). Isoﬂurane anes-
thesia (4% (vol/vol)) was initially given through a facemask to facilitate
tracheostomyand intubationandwasmaintained throughout (3%during
surgery and 2% otherwise). Piglets had mechanical ventilation adjusted
to maintain partial pressures of oxygen (PaO2) and carbon dioxide
(PaCO2) at 8–13 kPa and 4.5–6.5 kPa, respectively allowing for arterial-
blood temperature correction.
An umbilical venous catheter was inserted for infusion of mainte-
nance ﬂuids (10% dextrose, 60 ml/kg/day), fentanyl (3–6 μg/kg/h), and
antibiotics (benzylpenicillin 50 mg/kg and gentamicin 2.5 mg/kg, every
12 h). An umbilical arterial catheter was inserted for continuous heart
rate (HR) and mean arterial blood pressure (MABP) monitoring and
intermittent measurement of blood PaO2, PaCO2, pH, electrolytes,
glucose and lactate (Abbot Laboratories, UK). Bolus infusions of col-
loid (Gelofusin, B Braun Medical Ltd., Emmenbrucke, Switzerland)
and inotropes maintained MABP at N40 mm Hg. All animals re-
ceived continuous physiological monitoring (SA Instruments, New
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Arterial line clotting was prevented by continually infusing 0.9%
saline (Baxter, Deerﬁeld, IL;1 ml/h) with heparin sodium added
(1 IU/ml).
Both common carotid arteries were surgically isolated at the level of
the fourth cervical vertebra and encircled by remotely controlled vascu-
lar occluders (OC2A, In Vivo Metric, Healdsburg, California, USA). Then
pigletswere positioned prone in a plastic pod and the head immobilised
in a stereotactic frame which included NIRS optodes placed against the
sides of the head. A 7 cm × 5 cm elliptical transmit–receive MRS
surface coil tuned to the 31P resonant frequency (51.6 MHz) was posi-
tioned on top of the head. NIRS and MRS data were acquired before,
during and up to 60 min after HI. MRS data were also acquired 24 h
and 48 h post HI.
Broadband NIRS
ForNIRSweused an “in house” constructed broadband spectrometer
previously used for other studies of piglet brain (Cooper and Springett,
1997; Springett et al., 2000a), and brain injury patients (Tisdall et al.,
2008a). Light from a stabilized tungsten halogen source was ﬁltered
with 610-nm long-pass and heat-absorbing ﬁlters, and transmitted to
an optode secured stereo-tactically against the left side of the head via
a 3.3-mm diameter glass, 7 m long optical ﬁbre bundle. This setup did
not cause any heating of the tissue or any other diverse effects. Light
incident on the detector optode (right side of head) was focused via an
identical ﬁbre bundle onto the 400-μmentrance slit of a 0.27-m spectro-
graph (270M, Instruments SA, France) with a 300-g/mm grating blazed
at 1000 nm. Optodes were co-linear over the ventromedial/temporal
region with a line passing through the brain centre. Spectra between
650 nm and 980 nm were continuously acquired every 1 min on a
cooled-charge coupled device detector (Wright Instruments, United
Kingdom) with the shutter open, giving a signal of 10,000–30,000 elec-
trons per digital conversion at 800 nm and about 1 nm dispersion per
pixel and an approximate spectral resolution of less than 5 nm. A refer-
ence spectrum was acquired and changes (Δ) in the brain concentra-
tions of HbO2, HHb, and oxidised CCO were determined using the
UCLn algorithm (Matcher et al., 1995) after correction for the wave-
length dependence of path-length (Essenpreis et al., 1993). The optical
set-up, optical algorithm and experimental methodology did not allow
us to measure the absolute baseline oxidation state of CCO. The optical
path length for the 840-nm water absorption feature was obtained by
ﬁtting the second differential of the attenuation spectra to the second
differential of the in vitro water signal between 800 and 880 nm and
assuming 85% cerebral water content (Matcher et al., 1994). Changes
in haemoglobin difference (Δ[Hbdiff] = Δ[HbO2] − Δ[HHb]; indexing
changes in brain oxygenation) and changes in total haemoglobin
(Δ[Hbtot] = Δ[HbO2] + Δ[HHb]; indexing cerebral blood volume)
were also calculated. The measurements of Δ[oxCCO], Δ[HbO2] and
Δ[HHb] are deﬁned to be zero at the point of ﬁrst measurement. Thus
their values over the course of the experiment represent the aggregate
change with respect to this ﬁrst measurement.
31P MRS
Simultaneously with NIRS, whole-brain 31P MRS was acquired with
1 min resolution using a 9.4 T Agilent spectrometer and non-localised
single-pulse surface-coil acquisition (repetition time 10 s, 6 summed
acquisitions per spectrum). MRS data were analysed using AMARES
(Vanhamme et al., 1997) as implemented in the jMRUI software (van
den Boogaart, 1997). Prior knowledge of the NTP multiplet structure
was used (ﬁtting doublets to α- and γ-NTP and a triplet to β-NTP)
but no assumption was made as to multiplet relative sizes. NTP is
predominately ATP and the latter contributes approximately 70% of
the NTP signal e.g. in the rat pup (Mandel and Edel-Harth, 1966). Thus
NTP changes during this experiment predominately reﬂected ATPchanges. Pi was ﬁtted using 4 separate components and PCr with a
single component. The following peak-area ratios were calculated:
Pi/epp, PCr/epp, and NTP/epp where epp = exchangeable phos-
phate pool = Pi + PCr + 2γ-NTP + β-NTP.
Hypoxia–ischemia
Baseline NIRS and MRS data were recorded for 10 min before HI. HI
was induced inside the MR scanner by remotely inﬂating the vascular
occluders around both common-carotid arteries, and simultaneously
reducing fractional inspired (Fi) O2 to 9% (vol/vol). During HI the
β-NTP peak height was continuously monitored using in-house
Matlab (Mathworks) software. The period from the start of HI to
when β-NTP had fallen to 40% of its baseline height is deﬁned as
“Initial HI”. At the end of Initial HI FiO2 was titrated to maintain
β-NTP peak height between 30% and 40% of baseline for 12.5 min
(the “Titration” period). At the end of Titration the occluders were
deﬂated and FiO2 normalised (the “Recovery” period).
Statistics
When grouped data are used results are mean (standard deviation).
Data were tested for normality prior to parametric statistics using an
Anderson–Darling normality test with a null hypothesis that the data
were normally distributed. Where data were normally distributed,
analysis of variance (ANOVA) compared grouped data with the signiﬁ-
cance of any difference being determined by a Student t-test. Where
data were not normally distributed, a Wilcoxon rank sum test was
used instead. Signiﬁcance was assumed for p b 0.05.
31P MRS ratios were plotted against Δ[oxCCO]. During Initial HI and
Titration plots were ﬁtted with a linear function as a ﬁrst level of analy-
sis. Additionally, in order to model any threshold change at a particular
Δ[oxCCO] the same plots were ﬁttedwith a double-linear function of the
following form:
y ¼ axþ b : xbA
y ¼ cxþ d : xNA
axþ b ¼ cxþ d : x ¼ A
ð1Þ
where y = 31P MRS ratio and x = Δ[oxCCO]; A is Δ[oxCCO] at the point
of gradient change. The ﬁnal condition ensures a continuous function
(however, note that it is not continuously derivable). For display plots
were transposed so point A was the origin. For recovery comparisons
plots were ﬁtted with only a linear function. Δ[oxCCO] and 31P MRS
ratios were expected to show heterogeneous recovery as measure-
ments during this period are an average over diverse populations of
cells recovering at different rates. The measured relationships between
Δ[oxCCO] and 31P MRS ratios were therefore not expected to reﬂect the
relationships in a single-cell and thus the double linear model was not
used for the recovery data [see the section “Interpretation of Results”].
Results
Physiology
Baseline 10-min average physiology measurements were all normal
for a newborn piglet. Table 1 shows mean physiology measurements
over all subjects at baseline, end of Initial HI and 10 min and 60 min
into Recovery. The mean duration of HI was 27.5 (3.8) min. During
Initial HI SpO2 was signiﬁcantly reduced due to decreased FiO2. MABP
decreased signiﬁcantly during HI and then normalised during Recovery.
HR was elevated during HI and early Recovery. Rectal temperature was
unchanged.
Table 1
Mean physiological data measured at baseline, Initial HI end, 10 min into Recovery and
60 min into Recovery. SpO2: arterial oxygen saturation, HR: heart rate, MABP: mean arterial
blood pressure.
Time Rectal temperature (°C) SpO2
(%)
HR
(beats/min)
MABP
(mm Hg)
Baseline 38.5 (0.8) 96.8 (2.3) 152 (19) 48.1 (5.6)
Initial HI end 38.1 (0.4) 44.1 (10.8)b 166 (23)a 32.6 (8.1)b
10 min recovery 38.1 (0.4) 94.4 (2.9) 166 (25)a 47.2 (11.5)
60 min recovery 38.3 (0.6) 95.8 (3.2) 159 (30) 47.4 (8.5)
Paired T-test vs baseline: ap b 0.05
Paired T-test vs baseline: bp b 0.01
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Fig. 1 shows temporal NIRS and 31P MRS measurements for each
piglet. During HI Δ[Hbtot] generally increased brieﬂy (mean maximum
during Initial HI period 5.2 (4.7) (range −0.1 to 19.3) μM) before
decreasing later (mean minimum during Titration period −6.7 (5.0)
(range −17.4 to 0.3) μM). During Recovery Δ[Hbtot] returned to base-
line or slightly less (mean maximum during Recovery period 3.1 (3.4),
range−4.2 to 10.5 μM). In all piglets Δ[Hbdiff] declined at HI initiation
(mean minimum during Initial HI period −59 (24) (range −127 to
−19) μM) with eventual regain towards baseline during Recovery
(mean maximum during Recovery period 2.0 (8.2), range −10.6 to
19.5, μM). There were no overall relationships between Δ[Hbtot] and
Δ[Hbdiff] at 1 h and NTP/epp at 1 h, 24 h or 48 h after HI.
Baseline 31P MRS ratios and Δ[oxCCO] are in Table 2. Δ[oxCCO] fell
rapidly at the start of HI minimising during Titration (mean minimum
during Titration period −4.5 (1.4) (range −2.1 to 7.2) μM) and then
increasing during Recovery: however, baseline was not reattained in
some piglets. During HI, PCr/epp decreased (mean minimum during
Initial HI and Titration periods 0.02 (0.02) (range 0.001 to 0.08)) and
Pi/epp increased (mean maximum during Initial HI and Titration
periods 0.91 (0.04), (range 0.81 to 0.98)). During HI NTP/epp brieﬂy
remained near baseline before decreasing (mean minimum during
Initial HI and Titration periods 0.04 (0.02) (range 0.004 to 0.09)) once
PCr/epp had declined substantially.
Outcomes
31P MRS ratios and Δ[oxCCO] 1 h into Recovery and NTP/epp 24 h
and 48 h after HI are in Table 3. Piglets were grouped according to
whether they: (a) died (including termination) before 48 h due to
physiological deterioration consequential to HI; or (b) survived to
48 h. Nine subjects died before 48 h: 4 had cardiac arrest between 24
and 48 h and 1 before 24 h; the remaining 4 were terminated within
3 h of HI because NTP/epp did not recover to baseline (experiment
continuation would have been unethical). The remaining 15 piglets all
survived to 48 h.
In piglets surviving to 48 h, by 1 h into Recovery PCr/epp had
recovered to baseline; Pi/epp remained higher and NTP/epp and
Δ[oxCCO] lower than at baseline (Table 3). In those dying before
48 h, 1 h into Recovery PCr/epp, Pi/epp, NTP/epp and Δ[oxCCO]
were all signiﬁcantly different from their baselines and from the 1-h
recovery values for those surviving to 48 h. The was no signiﬁcant
difference in either Δ[Hbtot] or Δ[Hbdiff] between the outcome groups
at 1 h recovery (t-test, p N 0.9 and p N 0.1 respectively).
Relationships between Δ[oxCCO] and MRS measures during Initial HI
and Titration
Figs. 2a–b demonstrate the rationale for double-linear ﬁtting NTP/
epp and Δ[oxCCO]. Fig. 2a shows all data for each piglet demonstratingoverall only a small NTP/epp decrease during initial Δ[oxCCO] decline
up to a threshold after which NTP/epp decreases faster. This threshold
point is deﬁned by A in the double-linear model (see Eq. (1)). Fig. 2b
shows the double-linear ﬁt for a single piglet.
Each 31P ratio was plotted against Δ[oxCCO] for each subject and had
both a linear and double-linear ﬁt. The statistics from these ﬁts are
in Table 4. For presentation the Δ[oxCCO] axes in Figs. 2c–e were
transposed such that Δ[oxCCO] = A was the origin. During early HI,
Δ[oxCCO] declines but NTP/epp is effectively buffered until PCr/epp has
fallen signiﬁcantly (Figs. 2c and e); mean PCr/epp when Δ[oxCCO] =
ANTP (A for the NTP/epp ﬁt) was 0.11 (0.04) (37% of baseline, p b 0.001
vs baseline, t-test). In Fig. 2c at Δ[oxCCO] = ANTP NTP/epp had declined
to only 0.21 (0.03) (86% of baseline; p b 0.001 vs baseline, t-test). The
mean gradient of NTP/epp vs Δ[oxCCO] for Δ[oxCCO] N ANTP was signiﬁ-
cantly lower than for Δ[oxCCO] b ANTP (Table 4). As a percentage of the
total fall in Δ[oxCCO] during HI (baseline Δ[oxCCO]–minimum Δ[oxCCO]
during HI) Δ[oxCCO] had fallen by 71 (12) % when Δ[oxCCO] = ANTP.
For Pi/epp, APi (i.e. A for the Pi/epp ﬁt) deﬁnes a threshold at which
the mean rate of change of Pi/epp with Δ[oxCCO] increases towards
the end of HI (Fig. 2d). At Δ[oxCCO] = APi, Pi/epp had doubled from
baseline to 0.53 (0.10) (p b 0.001 vs baseline, t-test). Themeangradient
of Pi/epp vs Δ[oxCCO] for Δ[oxCCO] b APi was signiﬁcantly higher than
for Δ[oxCCO] N APi (p b 0.0001, t-test).
The PCr/epp vs Δ[oxCCO] plot is shown in Fig. 2e with a single linear
ﬁt. There was no signiﬁcant difference in the mean gradient of PCr/epp
vs Δ[oxCCO] in the regions Δ[oxCCO] N APCr and Δ[oxCCO] b APCr
(Fig. 2e). There were no signiﬁcant differences between ANTP and APi
for each subject (p N 0.9, paired t-test). Fig. 2f shows the ANTP and APi
correlation. There were also no signiﬁcant correlations between ANTP
and APCr or between APi and APCr.
Relations between Δ[oxCCO] and MRS measures during Recovery
Fig. 3 shows MRS ratios plotted against Δ[oxCCO] during Recovery
with died and survived groups plotted separately. Statistics from these
ﬁts are in Table 4. 31P ratio and Δ[oxCCO] recovery were signiﬁcantly
lessened for piglets dying before 48 h (Table 4). Overall 31P ratio vs
Δ[oxCCO] linear-ﬁt gradients were signiﬁcantly larger in the survivor
group. 31P ratio vs Δ[oxCCO] correlations were also weaker (smaller
mean R2) for piglets dying before 48 h (Table 4; p b 0.01 for all
comparisons; t-test).
Discussion
We used 31P MRS to study brain high-energy phosphates and NIRS
to study the oxidation status of cytochrome oxidase in the brain with
the aim of elucidating the relationships between these measurements
during and after HI. We demonstrated that the extent of recovery of
Δ[oxCCO] and 31P MRS metabolite ratios were associated during the
early period of recovery post HI. During HI, PCr/epp appears to decline
linearly withΔ[oxCCO]. The majority of the decline in NTP/epp occurred
after PCr/epp has decreased to approximately 1/3rd of its baseline value.
Thus there was a clear threshold, ANTP, in the NTP/epp vs Δ[oxCCO]
plots where the gradient of the regression line changed signiﬁcantly.
Similarly, there was a threshold point, APi, where the gradient of
the Pi/epp vsΔ[oxCCO] curve increased signiﬁcantly; ANTP and APi corre-
lated signiﬁcantly. During recovery, animals that survived to 48 h
demonstrated a more complete recovery of 31P MRS ratios and
Δ[oxCCO]; animals that died or were terminated prior to 48 h had
weaker recovery of both 31P MRS ratios and Δ[oxCCO].
The model
The piglet asphyxia model used in the current study has strong pre-
clinical value; it allows intensive care to be applied as it would be in an
intensive care setting in the clinic, thus maintaining metabolic and
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delayed appearance of abnormalities observed on 31P MRS spectra in
human neonates acquired in the early period after birth (Hope et al.,
1984). The data acquired from the model has relevance to the human
newborn with hypoxic–ischaemic encephalopathy. MRS biomarkers
are known to change during and after HI (Lorek et al., 1994), serve as
linking biomarkers in infants with HIE (Cheong et al., 2006) and areTable 2
Mean 31PMRS ratios andΔ[oxCCO]measured during10 min of data acquisition at baseline.
Δ[oxCCO] is deﬁned to be zero at the ﬁrst measurement. Thus the value for Δ[oxCCO]
represents the mean change during the baseline measurement period (see the section
“Broadband NIRS”). Data are presented stratiﬁed according to outcome at 48 h (survived
or died) and without stratiﬁcation (survived plus died). No signiﬁcant differences were
seen between the outcome groups at baseline.
Outcome Group PCr/epp Pi/epp NTP/epp Δ[oxCCO] (μM)
Survived to 48 h 0.31 (0.02) 0.24 (0.03) 0.25 (0.02) 0.09 (0.38)
Died pre 48 h 0.29 (0.02) 0.26 (0.03) 0.25 (0.02) 0.25 (0.60)
Survived plus died 0.30 (0.02) 0.25 (0.03) 0.25 (0.02) 0.15 (0.47)used as surrogate outcomemeasures in neuro-protection trials. Further-
more, the timing and evolution of cerebral 31P and 1H MRS biomarkers
are similar in the piglet following HI and the regional pattern of injury
is similar to that observed in humans and in primate models (Myers,
1975). Importantly, several neuro-protection studies performed in the
piglet model have provided proof of concept data for subsequent trans-
lational studies in newborn babies in the clinic, for example therapeutic
hypothermia (now standard therapy for HIE) (Tagin et al., 2012), xenon
augmented hypothermia (Faulkner et al., 2011), melatonin (Robertson
et al., 2012a) and amiloride (Robertson et al., 2012b). This study howev-
er furthers our understanding in thatwe deﬁne particular thresholds for
NTP below which the correlation between NTP and CCO changes
dramatically.
The double-linear model
Visual inspection of thedata suggested that the relationship between
NTP/epp and Δ[oxCCO] during HI was similar in each subject in terms of
the pattern of change but heterogeneous in terms of the absolute values
of Δ[oxCCO]. The double-linear model was used to extract the general
features of the relationship between NTP/epp and Δ[oxCCO] rather
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chemistry. Nevertheless the parameter A in the model does deﬁne a
speciﬁc reference position on the Δ[oxCCO] axis. The raw data in Fig. 2a
demonstrate well the heterogeneity of the Δ[oxCCO] signal across the
subject group. By transposing each dataset such that A = 0, as illustrated
in Fig. 2c, the general pattern of the relationship between NTP/epp
and Δ[oxCCO] can be more easily seen. This model was extended to in-
vestigate the relations between Pi/epp and Δ[oxCCO] and between PCr/
epp and Δ[oxCCO].
Additionally, each datasetwasﬁttedwith a linear function. In general,
care must be taken to avoid over-specifying the model function; usually,
when ﬁtting two functions to the same data, it is feasible to perform a
statistical comparison to determine whether the more complex function
yields a better ﬁt to the data. However, in this case, the linear regression
line is simply equivalent to a special-case solution to the double linear
model where the gradient is identical either side of point A. Thus the
R2 value for the double-linearmodel ﬁt will always be≥R2 from a simple
linear regression. A statistical comparison of the model function ﬁts
(for example by F-test of the residuals to the regression lines) is therefore
likely to be meaningless. For the NTP/epp vs Δ[oxCCO] and the Pi/epp vs
Δ[oxCCO] datasets there was a signiﬁcant change in the gradient of the
regression line at point A. Furthermore, there was a signiﬁcant correla-
tion between ANTP and APi. This is taken as evidence that ANTP and APi
have some physical signiﬁcance in these data and is our justiﬁcation for
considering the ﬁts to the double-linear model when discussing these
data in further detail below. In contrast, for the PCr/epp vs Δ[oxCCO]
datasets therewas no signiﬁcant change in gradient at APCr and no corre-
lation between APCr and either ANTP or APi. Thus the results of using a
simple linear regression to these data are considered in the discussionTable 3
31PMRS ratios andΔ[oxCCO]measured at 1 h into Recovery and alsoNTP/eppmeasured at 24 h
for each animal alongwith outcome-groupmeans. Groupmeans were tested for differences at 1
come groups. Where animals had died prior to MRS measurement at 24 h or 48 h, the table en
Subject number 1 h after HI
PCr/epp Pi/epp NTP/e
Survived to 48 h
1 0.34 0.27 0.19
2 0.34 0.22 0.23
3 0.33 0.28 0.21
4 0.33 0.31 0.19
5 0.31 0.28 0.22
8 0.34 0.29 0.20
10 0.31 0.28 0.23
11 0.30 0.33 0.22
12 0.30 0.28 0.25
13 0.32 0.27 0.24
14 0.32 0.29 0.22
16 0.29 0.35 0.19
19 0.32 0.31 0.21
21 0.30 0.31 0.23
23 0.32 0.30 0.21
Survivor group means 0.32 (0.02) 0.29b (0.03) 0.22b
Died before 48 h
6 0.15 0.65 0.11
7 0.09 0.79 0.07
9 0.16 0.63 0.12
15 0.14 0.71 0.09
17 0.21 0.50 0.16
18 0.15 0.65 0.12
20 0.19 0.57 0.13
22 0.05 0.91 0.03
24 0.13 0.70 0.10
Died group means 0.14b,c (0.05) 0.68e,f (0.12) 0.10e
Paired t-test vs baseline: ap b 0.05, bp b 0.01.
T-test vs 1 h recovery in survivors: cp b 0.01
Wilcoxon Rank Sums test vs baseline: dp b 0.05, ep b 0.01
Wilcoxon Rank Sums test vs 1 h recovery in survivors: fp b 0.01below. For completeness the results of both the double-linear model
and simple linear model ﬁts are included in Table 4.
Response of the brain during HI
For the analysis of the data acquired during HI, all subjects were
analysed as a single group. There was no difference between the
subjects at baseline when stratiﬁed according to outcome group
(see Table 2) and no justiﬁcation for stratifying subjects at this stage.
A model of the biochemistry of the piglet brain during anoxia has
been previously developed to simulate NIRS and MRS data (Moroz
et al., 2012) and this informs much of the following discussion of the
experimental changes seen in this work. Δ[oxCCO] is closely linked to
the production of ATP and, by extension, the 31P MRS measurement of
NTP/epp. We interpret a decreased Δ[oxCCO] as impairment of the
electron transport chain (ETC) which in turn results in failure of ATP
production through ATP synthase. The double-linear model deﬁnes
the point ANTP at which there is a threshold change in the relationship
between NTP/epp and Δ[oxCCO]. During the initial period of HI,
Δ[oxCCO] declines and so does ATP synthase. During this period, ATP
levels are initially buffered through the creatine kinase reaction leading
to a decline in PCr (Lawson and Veech, 1979). At the ANTP point, NTP/
epp has reduced only slightly whereas PCr/epp is severely depleted at
approximately 1/3rd of its baseline value. Eventually, after the ANTP
point, the depletion of PCr causes ATP to decline and therefore NTP/
epp declines faster with Δ[oxCCO]. The model of Moroz, along with
experimental data (Korzeniewski and Zoladz, 2001), suggests that the
reaction rate for ATP hydrolysis remains high until ATP concentrations
are severely depleted. Thus Pi is produced as a by-product and, becauseand 48 h.Data are stratiﬁed according to outcome at 48 h (survived or died). Data are given
h, 24 h and 48 h compared to baseline values and for differences at 1 h between the out-
try is left blank.
Outcome
pp Δ[oxCCO] (μM) NTP/epp24 h NTP/epp48 h
0.14 0.26 0.25
0.20 0.25 0.24
−0.49 0.23 0.24
−1.07 0.24 0.24
−0.33 0.24 0.24
0.04 0.22 0.24
−0.59 0.21 0.22
−0.57 0.24 0.23
0.88 0.22 0.23
−0.15 0.24 0.21
−0.54 0.25 0.23
−0.69 0.24 0.24
0.08 0.24 0.23
−0.89 0.22 0.21
−0.36 0.22 0.12
(0.02) −0.29d (0.50) 0.23b (0.01) 0.22b (0.03)
−1.48 0.02 −
−2.88 0.04 –
−1.23 – –
−1.79 0.04 –
−1.71 – –
−4.34 0.14 –
−0.19 – –
−4.35 – –
−3.76 – –
,f (0.04) −2.41e,f (1.48) – –
Table 4
Regression analysis ofΔ[oxCCO] plotted against each 31P MRS ratio during HI and Recovery. For data acquired during the HI period, summary data for both single linear and double-linear
ﬁts (see Eq. (1) in the section “Statistics”) are given in the table. Fitting with a double-linear model, slope a was signiﬁcantly different to slope c for NTP/epp and Pi/epp. For data acquired
during the Recovery period, summary data are given for single linear ﬁts stratiﬁed according to outcome at 48 h. Fitted slopes were signiﬁcantly lower in the Died group compared to
Survivors.
31P MRS ratio During HI During Recovery
Single linear ﬁt Double linear ﬁt Single linear ﬁt
Slope
(μM−1)
Mean R2 Slope (a) (μM−1) Slope (c) (μM−1) Δ[oxCCO] at point A (μM) Mean R2 Outcome group Slope
(μM−1)
Mean R2
NTP/epp 0.04 (0.01) 0.50 (0.18) 0.14 (0.09) 0.013 (0.017)a −2.7 (1.1) 0.79 (0.14) Survivors 0.04 (0.02) 0.60 (0.27)
Died 0.01 (0.01)c 0.23 (0.21)b
Pi/epp −0.14 (0.05) 0.79 (0.12) −0.27 (0.13) −0.11 (0.10)a −2.7 (1.3) 0.92 (0.07) Survivors −0.14 (0.08) 0.71 (0.27)
Died −0.03 (0.07)c 0.34 (0.25)b
PCr/epp 0.06 (0.02) 0.81 (0.17) −0.17 (1.3) 0.08 (0.06) −2.1 (1.1) 0.88 (0.13) Survivors 0.07 (0.04) 0.68 (0.27)
Died 0.02 (0.03)c 0.31 (0.24)b
T-test slope c vs slope a: ap b 0.0001.
T-test died vs survivor group: bp b 0.01, cp b 0.001.
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Fig. 2. Correlations between 31Pmetabolite ratios andΔ[oxCCO]. (a) NTP/epp plotted againstΔ[oxCCO] during HI (all data shown; different symbols for individual piglets). The relationship
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Fig. 3.MRS ratios plotted against Δ[oxCCO] during Recovery. Data from all animals are shown. Data are stratiﬁed according outcome. Plots a (NTP/epp), c (Pi/epp) and e (PCr/epp)show
data from those animals that survived to 48 h. Plots b (NTP/epp), d (Pi/epp) and f (PCr/epp) show data from animals that died before 48 h. Dark lines on each plot are overall linear
regression lines calculated using data from all animals. Recovery slopes are signiﬁcantly less steep for piglets dying before 48 h.
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different from ANTP, the slope of the Pi/epp vs Δ[oxCCO] plot increases.
Presumably, as NTP/epp starts to fall quickly at this point, there is now
little production of ATP via ATP synthase. The increase in the slope of
Pi/epp vs Δ[oxCCO] may therefore reﬂect the continuing demand for
ATP (ATP is not yet severely depleted at the ANTP point) along with
now much reduced re-combination of Pi into ATP via ATP synthase.
We speculate that the ANTP and APi points represent the point at which
ATP manufacture via all pathways is almost completely suppressed.
Furthermore, at this point over 2/3rds of the eventual reduction of
Δ[oxCCO] has occurred suggesting that the majority of the reduction in
Δ[oxCCO] occurs during the period where ATP manufacture via ATP
synthase declines. The change in the slopes of the NTP/epp vs Δ[oxCCO]
and the Pi/epp vs Δ[oxCCO] regression lines and the strong correlation
between ANTP and APi are further evidence that the decline in Δ[oxCCO]
represents the decline in ETC activity in this model.Response of the brain during recovery
During recovery from HI, the electron transport chain activity
recovers and Δ[oxCCO] starts to recover as oxidative phosphorylation
resumes. This leads to Pi reduction as it combines with ADP to produce
ATP. The production of ATP causes PCr reserves to be restored via
creatine kinase and recovery of both NTP/epp and PCr/epp is observed
on 31P MRS.
Nine piglets showed poor recovery during the ﬁrst hour post HI and
had to be terminated prior to 48 h post HI because of the extent of their
injury. The HI in this experiment is severe and is designed to induce
brain injury. The parameters of the HI were carefully controlled and
reproduced in each experiment. The level of NTP was monitored in
real time during HI and the FiO2 adjusted during Titration to ensure
that β-NTP peak height was held between 30% and 40% of its baseline
value. Despite a similar level of hypoxia–ischaemia in our model, there
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aetiology, extent of hypoxia and ischaemia, maturational stage of the
brain, regional cerebral blood ﬂow and general health of the subject
all inﬂuence the response to injury. This is similar to the heterogeneous
response to injury seen in human fetuses and babies. After HI,Δ[oxCCO],
PCr/epp and NTP/epp remained lower and Pi/epp remained higher
in these animals than in survivors. ATP levels in early recovery are
dependent on the severity of HI with lower ATP levels correlating with
longer periods of ischemia (Nishijima et al., 1989; Phillis et al., 1996).
Indeed, the response of NTP/epp during and for 1 h after HI has
previously been used as a measure of insult severity (O'Brien et al.,
2006). Furthermore, 31P metabolite ratios 2 h post HI can be used as
early markers of the likely extent of injury with increased Pi/epp and
decreased PCr/epp and NTP/epp correlating with poor outcome in the
piglet at 48 h (Cady et al., 2008). The MRS ratios measured during the
early recovery period are consistent with early markers of adverse
outcome.
Factors affecting the measurements of 31P MRS and NIRS biomarkers
MRS was performed using a simple pulse-acquire sequence, and the
signal was localised to the brain by using a surface coil in transmit and
receive mode. The dimensions of the coil limit the volume over which
MRS signals are acquired and so effectively localise the signal acquisi-
tion to the brain. NIRS data were acquired in transmission mode with
optodes positioned on the right and left hand sides of the head at
approximately the middle part of the brain. The use of transmission
mode for NIRS is a signiﬁcant development compared to previous
studies (Cooper and Springett, 1997; Springett et al., 2000a). The surface
coil used for MRSwas sufﬁciently large to acquire signals from the deep
greymatter nuclei aswell as the superﬁcial structures of the brain. Com-
putational simulations suggest that transmission mode NIRS affords
greater sensitivity to deeper structures (Gunadi and Leung, 2011) than
does reﬂection mode. The data from both modalities represent an aver-
age over both superﬁcial and deep brain structures. Although the posi-
tioning of the coil and optodes was arranged such that data were
acquired from similar volumes of tissue, the weights of contributions
from different brain structures will be different—31P data are more
weighted to superﬁcial structures given the positioning of coil on the
top of the head.
31P MRS data are given as metabolite peak-area ratios. Referencing
to epp allows separate interpretation of PCr, Pi and NTP changes and
there is evidence (Cady et al., 2008) that these ratios are more sensitive
to abnormalities than the PCr/Pi ratio used in many previous studies.
However, the 31P biomarkers are not direct concentration measure-
ments. Interpreting changes in metabolite/epp ratios as equivalent
changes in the concentration of the metabolite relies on an additional
assumption that the net contributions of PCr, Pi and NTP to the total
visible phosphorus pool is unchanged through the course of the
experiment.
The NIRS measurements in this work are of relative changes there-
fore we cannot directly estimate tissue oxygen saturation. Previously
Springett et al. (2000b) estimated tissue saturation after calibrating
the system to complete anoxia. However, this was not within the
scope of this work. Given that Δ[oxCCO] is a measurement only of the
change in oxidation state of CCO, there is no information about the
absolute value of [oxCCO] at baseline and no a priori knowledge as to
the concentration of mitochondria in the brain. The optical set-up,
optical algorithm and experimental methodology did not allow
us to measure the absolute baseline oxidation state of the CCO.
Previously a methodology has been described to quantify absolute
deoxyhaemoglobin (Matcher and Cooper 1994). Recently the abso-
lute oxidation of CCO has been using light in the visible spectrum
(Sakata et al., 2012). We are actively pursuing the development of
new instrumentation to quantify independently the absorption
and scattering and hence, using the independent spectra of theoxidation and the reduced CCO, to quantify its absolute redox
state (Tachtsidis et al., 2010).
Factors affecting Δ[oxCCO]
Mathematical modelling suggests that an increased substrate supply
of electrons reduces [oxCCO] and increased oxygen supply oxidises
[oxCCO] (Banaji, 2006). Experimentally, other factors such as pH and
mitochondrial inhibitors may explain other small changes in Δ[oxCCO]
(Cooper and Springett, 1997). During HI, decreased substrate supply
and reduced oxygenation would have an opposite effect on the oxida-
tion states of electron transport chain intermediates and, consequently,
on Δ[oxCCO]. In the fetal sheep, Δ[oxCCO] has been observed to increase
during 25 min of complete occlusion of the umbilical cord (Bennet et al.,
2007) and during occlusion ofmaternal common internal iliac artery for
1 h (Newman et al., 2000). Bennet et al. speculate that increased
Δ[oxCCO]during occlusion is a result of reduced substrate supply of elec-
trons during occlusion suggesting a rapid decrease inmetabolic activity.
In the naïve healthy piglet brain, small changes in oxygen delivery do
not induce concurrent changes in Δ[oxCCO] (Quaresima et al., 1998);
reductions inΔ[oxCCO] typically reﬂect larger scale reductions in oxygen
supply. Furthermore, Tsuji et al. (1995) have shown in the piglet that
hypoxia with 12% and 8% FiO2 produced slight increases in Δ[oxCCO]
whereas only formore severe hypoxias didΔ[oxCCO] reduce. Our obser-
vation of a profound reduction in Δ[oxCCO] during HI is consistent with
previous observations in the piglet (Springett et al., 2000a). The reasons
for the differences in the data from pigs and sheep are not clear but data
from individual models appear consistent.
Interpretation of results
The NIRS and 31PMRS data acquired in this study are averagedmea-
surements on thewhole brain. The evolution of the 31Pmetabolite ratios
during HI has been described in the section “Response of the Brain
during HI” in terms of the biochemistry that is happening at a cellular
level despite that fact that the data originate from a heterogeneous pop-
ulation of cells. We speculate that this description is possible because
during acute HI the cells are responding similarly and approximately
simultaneously to a global stimulus such that the average signals over
the bulk tissue represent a good approximation to the changes occur-
ring at a single cellular level. The relationships between 31P metabolite
ratios andΔ[oxCCO] therefore provide some insight into the signiﬁcance
of Δ[oxCCO] decline during HI, in particular that this likely represents
the decline in ETC activity. In contrast, recovery from HI is likely to be
heterogeneous (Vannucci et al., 2004). It is likely that there will be dif-
ferent populations of cells that differ in both the extent and rate of
their recovery. Thus, the observed pattern of recovery of 31P metabolite
ratios is likely to be a poor representation of the pattern of change at a
single cellular level. Similarly, the observed relationships between 31P
metabolite ratios and Δ[oxCCO] are less likely to accurately describe
the true relationships at a single cellular level. Nevertheless, these
data may provide an index of the averaged extent of recovery in the
brain. Persisting reduced NTP/epp in the Recovery period after restora-
tion of oxygen supply suggests synthesis of ATP is either impaired or
absent. Thus this implies either impaired mitochondrial function or
cell death. In the poor outcome group there was poor recovery of both
Δ[oxCCO] and NTP/epp. This suggests that mitochondrial metabolism
is not now generating ATP and that, in this model, continuedmitochon-
drial impairment after HI may be the cause of continued suppression of
Δ[oxCCO].
Translation to the clinic
The NIRS system used in this study was in-house developed and
adapted to monitor human neonates. It is based on using multiple
wavelengths (not just two or three discreet wavelengths) to improve
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2008b). The instrumentation operation and applicability is similar to
other commercial NIRS systems. Movement artefacts can affect the
signals therefore careful consideration is needed regarding the applica-
tion of the optode holder to the head. Measurement of the oxidation
state of CCO has the potential to provide information about the severity
of HI and whether the brain is recovering in the early period after birth.
However, it is also true that the oxidation state of naïve brain before
the insult is not known and hence the comparison with the injured
oxidation state cannot be made. The development of absolute mea-
surement of oxCCO will simplify the clinical interpretation. Never-
theless, in this study we demonstrated that oxCCO measurement is
a potential marker of metabolism in the brain independent from
the haemoglobin/oxygenation measurement. Measurement of the
trend of Δ[oxCCO] over time after the injury is likely to indicate
the degree of development of SEF and hence will be useful to collect
to determine the extent of recovery of the brain.
Conclusions
We have demonstrated the monitoring in-vivo of the metabolic
events during and following HI with high temporal-resolution.
During HI there are signiﬁcant correlations between 31P MRS ratios
and Δ[oxCCO]. Both NTP/epp and Pi/epp exhibit a signiﬁcant change
in their relations with Δ[oxCCO] at the point when PCr/epp becomes
severely depleted. During recovery those animals that survived to
48 h demonstrated more complete recovery of 31P MRS ratios and
Δ[oxCCO] than those who subsequently develop secondary energy
failure.
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